WASHINGTON, D.C., March 28, 2023 – James (Jim) Potter has been named the new Executive Director for the Coalition of Healthcare Communications (CHC), following the retirement of Jon Bigelow, and its acquisition by the American Association of Advertising Agencies (4A’s) in 2022. The acquisition was made to enable the CHC to expand their capabilities for […]
Read more
Nov. 29, 2022 – Americans are enrolling in Affordable Care Act (ACA) marketplaces for 2023 at what appears to be a record-setting pace as healthcare becomes less of a political football. According to a report from President Joe Biden and Department of Health and Human Services (HHS) Secretary Xavier Becerra, nearly 3.4 million people have […]
Read more
Nov. 14, 2022 – The public health landscape has changed dramatically since the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (Pasteur Act) – a bill that would address the significant and growing problem of antibiotic, antifungal and antiviral resistance – was introduced three years ago and every year since, but despite the ongoing need […]
Read more
Oct. 18, 2022 – The Centers for Medicare & Medicaid Services (CMS) is beginning to establish a framework for the Medicare drug pricing negotiations mandated in the recently enacted Inflation Reduction Act (IRA), a process that will be complicated and controversial. “Passage of the Inflation Reduction Act – including provisions to mandate Medicare negotiations on […]
Read more
Sept. 13, 2022 – In a decision that could have ramifications for preventive care efforts across the United States, last week a ruling from Texas’ U.S. District Judge Reed O’Connor held that a provision of the Affordable Care Act (ACA) requiring most private health plans to cover specified preventive services and prescription drugs at no […]
Read more
Aug. 30, 2022 – When members of the House and Senate return to Washington Sept. 6 following the Labor Day holiday, they face competing priorities and tight timeframes to take action on the federal budget and user fees, which expire on Sept. 30. Failure to pass the fiscal year 2023 (FY 2023) budget and reauthorize […]
Read more
Aug. 22, 2022 – For years, the issue of regulating data privacy has been addressed largely by individual states, with little comprehensive action on the federal level. But that may be about to change in light of a more aggressive Federal Trade Commission (FTC), a new bipartisan proposal in Congress, and the U.S. Supreme Court’s […]
Read more Aug. 15, 2022 — The Inflation Reduction Act passed last week may represent the best outcome the biopharma industry reasonably could have hoped for at a time when so many in Congress are eager to respond to strong public opinion that prescription prices are too high. The new legislation, which reins in some drug costs […]
Read more July 18, 2022 – With just days left before a deadline to send layoff notices to thousands of Food and Drug Administration (FDA) staff, legislation to reauthorize prescription drug user fees – which fund half of the FDA’s budget – has not yet been passed. Although Congress is well aware of both the Sept. 30 […]
Read more
July 11, 2022 – Providing a new pathway for drug companies and consumers that would enable additional drugs to become available without a prescription is the goal of a recent proposed rule from the Food and Drug Administration (FDA). The proposed rule, issued on June 28, would allow the FDA to approve nonprescription drug products […]
Read more